Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 1,565.80
-4.30 (-0.27%)
Apr 2, 2026, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 119.17 billion as of April 2, 2026. Its market cap has decreased by -17.95% in one year.
Market Cap
119.17B
Enterprise Value
110.20B
Revenue
20.92B
Ranking
n/a
PE Ratio
19.42
Stock Price
1,565.80
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 119.17B, an increase of 2,128,403.98%. That is a compound annual growth rate of 51.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 119.17B | -14.85% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 191.04B |
| Piramal Pharma | 181.30B |
| Eris Lifesciences | 179.72B |
| NATCO Pharma | 174.49B |
| Alembic Pharmaceuticals | 130.37B |
| Alivus Life Sciences | 119.39B |
| Cohance Lifesciences | 115.32B |
| Strides Pharma Science | 86.43B |